FDA approval would send North American Vaccine into a $ 300 million market for the new safer whooping cough vaccines, which has seen strong entries from SmithKline Beecham Plc, American Home Products Corp . and Rhone Poulenc SA in the last two years.
32.
Abbott shares rose 3 / 8 to 46 1 / 4 after the maker of health-care products said it will invest $ 42 million in North American Vaccine Inc ., and will market North American's diphtheria, tetanus and whooping cough vaccine after it gets Food and Drug Administration approval.
33.
Abbott Laboratories rose 3 / 8 to 46 1 / 4 after the drugmaker said it will invest up to $ 42 million in North American Vaccine Inc ., giving it the right to sell North American's diphtheria, tetanus and whooping cough vaccine, DTaP, once it wins U . S . approval.
